Terrie Curran, President and Chief Executive: Phathom Pharmaceuticals PHAT Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $125,928.31
Shares · price: 19,109 sh · $6.59 a share
Held after: 360,465 sh
Stock: Phathom Pharmaceuticals PHAT
Person: Terrie CurranPresident and Chief Executive
Trade date: 25/01/21
Filed: 25/01/23
Days to filing: 2 days

Sold 5.0% of holdings

Share of holding sold: 5.0%

Phathom Pharmaceuticals trades, last 26 weeks

What else happened in Phathom Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/22~25/02/20

Terrie Curran's recent trades

Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$956.1K
38,200 sh
$956.1K
Filed 08/27
Traded 08/27
Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$27.9K
1,072 sh
$27.9K
Filed 08/20
Traded 08/20
Terrie CurranDirector
SellArcutis Biotherapeutics
Sell
Arcutis Biotherapeutics
ARQT
$94.3K
8,687 sh
$94.3K
Filed 24/11/13
Traded 24/11/11
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$396.7K
33,848 sh
$396.7K
Filed 24/07/17
Traded 24/07/15
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$153.5K
16,851 sh
$153.5K
Filed 24/03/26
Traded 24/03/22